Runners and riders in the Covid vaccine race
Pfizer, AstraZeneca and Moderna have gained approval for their Covid vaccines from the British isles regulator and the jabs are by now getting rolled out. But what about the other vaccine candidates and how quickly will they appear to sector?
Our listing offers a snapshot of what the vaccine landscape seems like.
The life sciences industry’s response to the pandemic has been unparalleled the two in phrases of the speed at which it has developed vaccines and its willingness to collaborate with rivals. That has resulted in 237 potential vaccines, of which 64 are in human clinical trials.
That’s great information as, in the vaccines business there is typically no “one particular-dimension-matches-all” solution, with different nations around the world demanding different types of vaccines primarily based on a range of variables such as local climate, land mass and demography. In other phrases: there is a great deal of room in the sector for a lot more than one particular vaccine.
Covid vaccines accepted by the British isles
Pfizer/BioNtech
British isles approval day: December 2, 2020
Doses: two
Efficacy: 90pc +
Variety: mRNA
Doses offered or pre-ordered globally: The total sum is undisclosed, but we know it has 300m on buy from the EU and 200m from the US, which, alongside one another with the British isles, provides the total to 540m
Doses procured by the British isles: 40m
Manufacturing capability: Up to 2bn doses this 12 months
